Fair Value Calculator Fair Value Calculator
EN DE

0264 (0264) Fair Value & Analysis

Consumer Cyclical · Market cap HK$1.1B

0 0264 0264 · HK
PriceHK$2.22
Fair ValueHK$2.95
Upside+32.9%
Quality52/100
Evidence: Low Range HK$2.71 – HK$3.31

Fair value as of: Jul 1, 2026

From 3 valuation models · updated today

Share price −5.9% over the past month.

Price vs Fair Value (12 months)

HK$3.19 HK$1.13 Fair Value HK$2.95 Jun 2025 Jun 2026

12‑month range HK$1.13 – HK$3.19 · fair‑value band HK$2.71 – HK$3.31 · the HK$2.22 price screens below the HK$2.95 fair value. As of Jul 1, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0264 (0264) currently trades at HK$2.22, while our model-based Fair Value estimate is HK$2.95 — implying the stock looks roughly 32.9% undervalued today. We read business quality at 52/100 (solid quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

Over the trailing twelve months, 0264 generated revenue of HK$59.3M at a net margin of -26.4%. Revenue grew 211.2% year over year. The balance sheet holds a net cash position of HK$1.5M. Fundamentals as of Jul 1, 2026

Key figures & financial health

Revenue (TTM) HK$59.3M
Revenue growth (YoY) +211%
Net margin -26.4%
Free cash flow −HK$18.9M FY2025
Operating margin -22.0%
EPS (TTM) HK$-0.0200
More key figures
Net cash HK$1.5M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0264 reported revenue of HK$59.3M in FY2025 versus HK$49.2M in FY2021, a compound +4.8%/yr. Reported net income was −HK$15.7M in FY2025.

Revenue +4.8%/yr
FY21 HK$49.2M
FY22 HK$56.0M
FY23 HK$30.3M
FY24 HK$22.0M
FY25 HK$59.3M
Net income
FY21 −HK$21.0M
FY22 −HK$18.9M
FY23 −HK$27.9M
FY24 −HK$17.1M
FY25 −HK$15.7M

Is 0264 fairly valued? → Check now

Similar stocks

6 more Footwear & Accessories stocks, each showing price versus our Fair Value estimate (as of Jul 1, 2026).

Stock Price Fair Value vs Fair Value
NIKE, Inc NKE €38.41 €31.09 -19%
adidas AG ADDYY $97.66 $62.93 -36%
ASICS Corporation ASCCY $25.77 $19.43 -25%
Deckers Outdoor Corporation DECK $108.96 $96.18 -12%
On Holding ONON $38.00 $18.63 -51%
Zhejiang China Commodities City Group 600415 ¥11.37 ¥23.62 +108%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 0264 (0264) undervalued?
As of Jul 1, 2026, our model estimates a fair value of HK$2.95 versus a price of HK$2.22 — about +33% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 0264?
Our model-based fair value for 0264 is HK$2.95 (as of Jul 1, 2026), built from audited fundamentals. The current price is HK$2.22.
What is the quality score of 0264?
0264 has a Quality Score of 52/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 0264 (0264)?
0264 reported trailing-twelve-month revenue of about HK$59.3M (latest available figure, as of Jul 1, 2026).
What is the net profit margin of 0264?
The net profit margin of 0264 is about -26.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.